KESTRA MEDICAL TECHNOLOGIES, LTD.
For the period ended Jan 31, 2025. Filed Apr 17, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2025 · Filed Apr 17, 2025
KMTS$28.80+0.9%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
KESTRA MEDICAL TECHNOLOGIES, LTD.
CONDENSED BALANCE SHEETS
(in dollars)
| January 31,2025 | April 30,2024 | |
|---|---|---|
| Assets | ||
| Total assets | $— | $— |
| Commitments and contingencies (Note 3) | ||
| Shareholder’s equity | ||
| Shares subscription receivable from West Affum Holdings, L.P. | (100) | (100) |
| Ordinary Shares, $1.00 par value; 100 shares authorized, issued and outstanding | 100 | 100 |
| Total shareholder’s equity | $— | $— |
See accompanying notes to the condensed balance sheets.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.